Atlas Trials

Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

Clinical trial NCT00356447 · COMPLETED

Trial details

NCT number
NCT00356447
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Vasomotor Symptoms
Start date
2006-05-01
Primary completion
2007-10-01
Enrollment
249

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.